{"id":"W4399543904","doi":"10.1007/s12325-024-02902-0","title":"De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate","year":2024,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Biogen","keywords":"Medicine; Fingolimod; Multiple sclerosis; Ocrelizumab; Internal medicine; Expanded Disability Status Scale; Adverse effect; Clinical trial; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001959862,0.0003735308,0.0006473097,0.0008148421,0.0007949633,0.00101799,0.0004584416,0.0006994905,0.0008358968],"category_scores_gemma":[0.003687823,0.000313853,0.001583573,0.0006496056,0.000277587,0.00081216,0.0007944336,0.0009502206,0.0002899203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005921834,"about_ca_system_score_gemma":0.000395431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003324081,"about_ca_topic_score_gemma":0.003783175,"domain_scores_codex":[0.9989988,0.0002591952,0.0001216265,0.0002074655,0.0001985843,0.0002142762],"domain_scores_gemma":[0.9982951,0.0001893801,0.000890572,0.00009181983,0.0002050455,0.0003281481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002645744,0.0005963869,0.9851053,0.0000739386,0.0004386892,0.0001500175,0.0005130499,0.0001268333,0.0004505033,0.00003642262,0.0002034531,0.009659667],"study_design_scores_gemma":[0.0001575902,0.00301549,0.9947768,0.00003890611,0.0002940693,0.0002309158,0.0003328481,0.0003856418,0.0002160708,0.00007453162,0.0004605841,0.0000163966],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990011,0.0002860915,0.00007591081,0.00003343274,0.000006150485,0.00003970024,0.0002569859,0.000003096424,0.0002976436],"genre_scores_gemma":[0.9990348,0.00009399356,0.00008797064,0.00008859426,0.0000125333,0.00006159107,0.0004581844,0.000001389886,0.0001610646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003324081,"threshold_uncertainty_score":0.01036483,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04441857967308863,"score_gpt":0.3346817676411522,"score_spread":0.2902631879680635,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}